Propanc Biopharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Propanc Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2018 to Q2 2024.
  • Propanc Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $11.5M, a 2.75% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $11.5M +$307K +2.75% Jun 30, 2024 10-K 2024-09-30
Q2 2023 $11.2M +$861K +8.37% Jun 30, 2023 10-K 2024-09-30
Q2 2022 $10.3M +$339K +3.41% Jun 30, 2022 10-K 2023-09-28
Q2 2021 $9.96M +$1.15M +13% Jun 30, 2021 10-K 2022-09-28
Q2 2020 $8.81M +$1.14M +14.8% Jun 30, 2020 10-K 2021-09-28
Q2 2019 $7.67M +$1.39M +22.2% Jun 30, 2019 10-K 2020-10-01
Q2 2018 $6.28M Jun 30, 2018 10-K 2019-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.